Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 7
2006 9
2007 6
2008 8
2009 8
2010 7
2011 8
2012 12
2013 16
2014 13
2015 19
2016 18
2017 19
2018 25
2019 25
2020 42
2021 51
2022 38
2023 40
2024 42
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Cuadripani S, Deraedt Q, Dezutter N, Gerard C, Fissette L, Xavier S, David MP, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 study group. Ison MG, et al. Among authors: papi a. Lancet Respir Med. 2025 Jun;13(6):517-529. doi: 10.1016/S2213-2600(25)00048-7. Epub 2025 Apr 14. Lancet Respir Med. 2025. PMID: 40245915 Clinical Trial.
Improved Annotation of Asthma Gene Variants with Cell Type Deconvolution of Nasal and Lung Expression Quantitative Trait Loci.
El-Husseini ZW, Karp T, Lan A, Gillett TE, Qi C, Khalenkow D, van der Molen T, Brightling C, Papi A, Rabe KF, Siddiqui S, Singh D, Kraft M, Beghé B, Joubert P, Bossé Y, Sin D, Cordero AH, Timens W, Brandsma CA, Hao K, Nickle DC, Vonk JM, Nawijn MC, van den Berge M, Gosens R, Faiz A, Koppelman GH. El-Husseini ZW, et al. Among authors: papi a. Am J Respir Cell Mol Biol. 2025 Jun;72(6):607-614. doi: 10.1165/rcmb.2024-0251MA. Am J Respir Cell Mol Biol. 2025. PMID: 39836087
129Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudy.
Smith LJ, Marshall H, Jakymelen D, Biancardi A, Collier GJ, Chan HF, Hughes PJC, Brook ML, Astley JR, Munro R, Rajaram S, Swift AJ, Capener D, Bray J, Ball JE, Rodgers O, Tahir BA, Rao M, Norquay G, Weatherley ND, Armstrong L, Hardaker L, Papi A, Hughes R, Wild JM. Smith LJ, et al. Among authors: papi a. Thorax. 2025 May 27:thorax-2024-222347. doi: 10.1136/thorax-2024-222347. Online ahead of print. Thorax. 2025. PMID: 40425296 Free article.
As-Needed Albuterol-Budesonide in Mild Asthma.
LaForce C, Albers F, Danilewicz A, Jeynes-Ellis A, Kraft M, Panettieri RA Jr, Rees R, Bardsley S, Dunsire L, Harrison T, Sobande O, Surujbally R, Trudo F, Cappelletti C, Papi A, Beasley R, Chipps BE, Israel E, Pandya H, Clancy M, Bacharier LB; BATURA Investigators. LaForce C, et al. Among authors: papi a. N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544. Online ahead of print. N Engl J Med. 2025. PMID: 40388330
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID; MATINEE Study Investigators. Sciurba FC, et al. Among authors: papi a. N Engl J Med. 2025 May 1;392(17):1710-1720. doi: 10.1056/NEJMoa2413181. N Engl J Med. 2025. PMID: 40305712 Clinical Trial.
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Maloney J, Dakin P, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM. Vogelmeier CF, et al. Among authors: papi a. Respir Med. 2025 May;241:108015. doi: 10.1016/j.rmed.2025.108015. Epub 2025 Feb 28. Respir Med. 2025. PMID: 40024335 Free article. Clinical Trial.
Personalised therapeutic approaches for asthma.
Agache I, Adcock IM, Baraldi F, Chung KF, Eguiluz-Gracia I, Johnston SL, Jutel M, Nair P, Papi A, Porsbjerg C, Usmani OS, Meyers DA, Zemelka-Wiacek M, Bleecker ER. Agache I, et al. Among authors: papi a. J Allergy Clin Immunol. 2025 Apr 7:S0091-6749(25)00375-6. doi: 10.1016/j.jaci.2025.03.025. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40203996 Review.
Climate Change & COPD: A GOLD Science Committee Review.
Halpin DMG, Balmes J, Han MK, Papi A, Martinez FJ, Montes de Oca M, Ozoh OB, Salvi S, Sin DD, Zheng J, Agusti A, Vogelmeier C. Halpin DMG, et al. Among authors: papi a. Am J Respir Crit Care Med. 2025 Mar 12. doi: 10.1164/rccm.202410-2058PP. Online ahead of print. Am J Respir Crit Care Med. 2025. PMID: 40072246 No abstract available.
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial.
Castro M, Papi A, Porsbjerg C, Lugogo NL, Brightling CE, González-Barcala FJ, Bourdin A, Ostrovskyy M, Staevska M, Chou PC, Duca L, Pereira AM, Fogarty C, Nadama R, Zhang M, Rodrigues A, Soler X, Sacks HJ, Deniz Y, Rowe PJ, de Prado Gómez L, Jacob-Nara JA. Castro M, et al. Among authors: papi a. Lancet Respir Med. 2025 Mar;13(3):208-220. doi: 10.1016/S2213-2600(24)00362-X. Epub 2025 Feb 10. Lancet Respir Med. 2025. PMID: 39947221 Clinical Trial.
393 results